We welcome the incisive comments from Cahill Lambert (page 472).1 The remit of our position statement2 was to update our previous evidence-based guidelines for the prescription of oxygen in Australia and New Zealand by reviewing the currently available literature. Informal consultation with consumers was made through the Australian Lung Foundation’s COPD (chronic obstructive pulmonary disease) Consultative Group, but no funding was available to seek broader community comment. Our position statement supports the use of ambulatory oxygen as part of continuous oxygen therapy in patients who fulfil criteria for long-term oxygen therapy — both to maximise the duration of normal blood oxygen concentrations and to maximise exercise capacity.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.